Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Avalide
print preview
bookmark
share with colleague
General Information
Company
Bristol-Myers Squibb Co.
Description
Combination of the angiotensin II receptor antagonist Avapro irbesartan and the diuretic hydrochlorothiazide
Molecular Target
Angiotensin II type 1 (AT1) receptor (AGTR1)
Mechanism of Action
Angiotensin II type 1 (AT1) receptor antagonist
Latest Stage of Development
Marketed
Indication
Hypertension
Partner
Sanofi
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy